Spectrum Pharmaceuticals Investor Relations Material
Latest events
Q4 2022
Spectrum Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Spectrum Pharmaceuticals Inc
Access all reports
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing and commercializing oncology and hematology drug products. It operates through the following segments: North American Sales, International Sales, and Research and Development. The company's product candidates include FUSILEV , ZEVALIN, VALSTAR, GAMMATOPHOS, KYTRIL, SUTENT, and VORAXAZE. It offers FUSILEV (levoleucovorin) oral granules, ZEVALIN (ibritumomab tiuxetan) for injection for the treatment of patients with indolent non-Hodgkin's lymphoma monitored by x-ray prior to treatment and during treatment cycle number one; cancer of the ovary or fallopian tube. Spectrum Pharmaceuticals, Inc. is based in Henderson, Nevada.
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
SPPI
Country
đșđž United States